KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $6.6 million.

  • Globus Medical's Non Operating Income fell 2577.79% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.8 million, marking a year-over-year increase of 162301.79%. This contributed to the annual value of -$45.3 million for FY2024, which is 24036.46% down from last year.
  • Per Globus Medical's latest filing, its Non Operating Income stood at $6.6 million for Q3 2025, which was down 2577.79% from $112.1 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Non Operating Income ranged from a high of $112.1 million in Q2 2025 and a low of -$35.6 million during Q4 2024
  • Moreover, its 5-year median value for Non Operating Income was $2.8 million (2022), whereas its average is $7.2 million.
  • Per our database at Business Quant, Globus Medical's Non Operating Income plummeted by 34395.81% in 2024 and then soared by 559064.18% in 2025.
  • Globus Medical's Non Operating Income (Quarter) stood at $1.6 million in 2021, then soared by 396.81% to $8.1 million in 2022, then skyrocketed by 83.86% to $14.9 million in 2023, then crashed by 339.44% to -$35.6 million in 2024, then surged by 118.62% to $6.6 million in 2025.
  • Its last three reported values are $6.6 million in Q3 2025, $112.1 million for Q2 2025, and $6.7 million during Q1 2025.